Artificial pump effectively supports patients with heart failureApril 3rd, 2009 - 4:29 pm ICT by ANI
Washington, Apr 3 (ANI): Patients awaiting heart transplant surgery can be supported with an artificial pump to keep their heart beating, according to a new study.
The device, called a left ventricular assist device (LVAD), is the latest generation of heart assist devices.
“LVADs have allowed us to support patients until they can receive a heart transplant, so they are called a bridge to transplant. For patients whose hearts are failing and are awaiting transplantation, these devices can be lifesavers,” said Gregory Ewald, M.D., a Washington University cardiologist at Barnes-Jewish Hospital and medical director of the Heart Failure, Cardiac Transplantation and Total Artificial Heart Program.
An LVAD is implanted inside the chest cavity near the heart and is connected to the heart’s left ventricle (pumping chamber).
It assists the patient’s weakened or damaged ventricle in pumping blood through the body. By restoring a normal blood flow, the device improves patients’ health. Because it is powered by portable battery packs, patients usually go home while they wait for a heart transplant.
The LVAD used in this study, the VentrAssist, is termed a third-generation heart assist device. Measuring 2.5-inches across and weighing 10 ounces, the pump is considered an improvement over earlier devices because its size and lightweight make it suitable for small adults and children.
In addition, its pumping mechanism has no contacting parts for improved durability.
Patients who received the LVAD in the study were approved and listed for cardiac transplantation. The study considered the device successful if a patient survived until heart transplantation or survived at least 180 days after the device was implanted and remained qualified for heart transplantation. Eighty-five percent of patients met this measure of success.
Out of 98 patients who received the device, 60 were transplanted, 19 continued to be supported with the device and 19 died. The median time on LVAD support was 131 days.
Adverse events reported during the trial included stroke and bleeding, and the number and type of adverse events was similar to other LVADs but better than that of first-generation VAD devices.
Answering standardized questionnaires for patients with heart failure, they reported a significantly improved quality of life after receiving the device, indicating that their heart failure was less apt to interfere with everyday activities such as housework, hobbies or sleeping or to affect their mood, ability to concentrate or energy level.
Results of this third-generation heart assist device were reported at the 58th annual meeting of the American College of Cardiology on March 30. (ANI)
- Implantable pump to help heart patients until transplant - Apr 03, 2009
- Rest can undo damage to heart cells - Apr 02, 2012
- Ex-US Vice-President Dick Cheney has pump placed in heart - Jul 15, 2010
- First 3 patients fitted with next-generation mechanical heart pumps in US - Jun 03, 2009
- Indian-American surgeon to bring low-cost heart therapy to India - Aug 04, 2012
- Heart-assist device keeps teenager alive until transplantation - Feb 13, 2010
- World's first new DeBakey heart assist device implanted successfully - Aug 18, 2009
- Dick Cheney's Weak Heart Undergoes The Implantation Of A 'Bridge To Transplant' Apparatus - Jul 15, 2010
- Heart pump keeps child alive until transplantation - Feb 13, 2010
- Dick Cheney Planted With 'Bridge To Transplant' - Jul 15, 2010
- 'Grafting helps normalise heartbeats' - Aug 06, 2012
- Device boosts libido of men with heart failure - Jun 02, 2011
- Top 10 major advances in heart disease in 2010 - Dec 22, 2010
- First US teen patient with implanted mechanical heart device discharged - Nov 12, 2009
- 15-year boy first to get robot heart transplant - Oct 03, 2010
Tags: artificial heart program, barnes jewish hospital, battery packs, blood flow, cardiac transplantation, cardiologist, chest cavity, ewald, heart beating, heart failure, heart transplant surgery, heart transplantation, left ventricular assist device, lifesavers, lvad, measure of success, medical director, normal blood, patients with heart failure, ventricle